"The Stock Market is designed to transfer money from the Active to the Patient." Warren BUFFETT	Donate with Paypal
- U.S.A. - Canada - U.K. - France - Germany - Japan - Hong-Kong	Merck - - DOW JONES 30 - Pharmaceuticals Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of products to improve human and animal health. MARGIN OF SAFETY of Merck : (not calculated) How is the Margin of Safety calculated ? QUALITY : Conservative Investors : Enterprising Investors : What are the Stars ? FORUMS VISIT Merck FORUM ! Alerts : no buy or sell alert What are the alerts ? Price over 1 year : PRICE, INTRINSIC VALUE & MARGIN OF SAFETY based on GRAHAM's FORMULA What is the Graham's Formula ? Merck price is : (as of 5/21/2009) USD Current Earnings per Share (2009 est.) are : USD Estimated Long Term Growth (% per Year) is : % INTRINSIC VALUE = MARGIN OF SAFETY = (not calculated) How is Long Term Growth estimated for Merck ? Historical analysis for Merck - See detail QUALITATIVE FILTERS FOR Merck What are the Stars ? DEFENSIVE ENTERPRISING COMPANY SIZE (MKT CAP. Mls $) Very Large 55,184 mls.$ OK The company's Market cap. is above 5000 millions dollars - FINANCIAL CONDITION Current Ratio 1.35 The current ratio is under 2 The current ratio is under 1.5 LT Debt/Net Curr. Assets 0.79 The LTdebt/current assets ratio is under 1 The LTdebt/current assets ratio is under 1.1 EARNINGS STABILITY Losses / 10 - 5 Years 0 / 0 No losses in the past ten years No losses in the past five years DIVIDENDS Years of Dividends 15 15 years of dividend in the past 15 years Current dividends paid EARNINGS GROWTH Growth 10-5 Years -10% / 10%% Total Earnings growth under 33% for the past 10 years Last year earnings above earnings 5 years ago VALUATION P.E. x P/Book 23.83 P.E. x P/Book is above 22.5 P/Book is above 1.20 P.E. 8.1 OK PE is under 15 - P/Book 2.94 NO P/Book is above 1.5 NO P/Book is above 1.2 Merck - Competitors for Pharmaceuticals   STOCK QUALITY Conservative Investors MARGIN OF SAFETY Long Term Growth Price / Earnings   Forest Labs - U.S.A. SP 500 Pharmaceuticals MARGIN OF SAFETY : 367.14 % Long Term Growth : 11.15 % Price / Earnings : 6.6 x 23.08 / 3.50 = Sanofi Aventis - France CAC 40 Pharmaceuticals MARGIN OF SAFETY : 326.34 % Long Term Growth : 11.13 % Price / Earnings : 7.2 x 43.88 / 6.08 = Biovail Corp - Canada TSE60 Pharmaceuticals MARGIN OF SAFETY : 214.09 % Long Term Growth : 14.34 % Price / Earnings : 11.8 x 14.56 / 1.23 = Pfizer - U.S.A. DOW JONES 30 Pharmaceuticals MARGIN OF SAFETY : 212.11 % Long Term Growth : 7.62 % Price / Earnings : 7.6 x 14.83 / 1.95 = Teva - U.S.A. Nasdaq 100 Pharmaceuticals MARGIN OF SAFETY : 161.19 % Long Term Growth : 13.27 % Price / Earnings : 13.4 x 44.28 / 3.30 = Merck - Germany DAX 30 Pharmaceuticals MARGIN OF SAFETY : 152.80 % Long Term Growth : 10.97 % Price / Earnings : 12.0 x 64.04 / 5.32 = Astellas Pharma - Tokyo Nikkei 225 Pharmaceuticals MARGIN OF SAFETY : 148.84 % Long Term Growth : 8.38 % Price / Earnings : 10.1 x 3260 / 321.20 = Bayer - Germany DAX 30 Pharmaceuticals MARGIN OF SAFETY : 146.93 % Long Term Growth : 10.23 % Price / Earnings : 11.7 x 39.3 / 3.35 = GlaxoSmithKline - U.K. FTSE 100 Pharmaceuticals MARGIN OF SAFETY : 134.07 % Long Term Growth : 6.36 % Price / Earnings : 9.1 x 1063.5 / 117.33 = Sun Pharma - India Nifty50 Pharmaceuticals MARGIN OF SAFETY : 131.48 % Long Term Growth : 13.45 % Price / Earnings : 15.3 x 1290.6 / 84.39 = Virbac - France Mid&Small 190 Pharmaceuticals MARGIN OF SAFETY : 127.68 % Long Term Growth : 9.52 % Price / Earnings : 12.1 x 52.36 / 4.33 = Eli Lilly - U.S.A. SP 500 Pharmaceuticals MARGIN OF SAFETY : 127.36 % Long Term Growth : 5.10 % Price / Earnings : 8.2 x 34.62 / 4.21 = Wyeth - U.S.A. SP 500 Pharmaceuticals MARGIN OF SAFETY : 122.12 % Long Term Growth : 9.76 % Price / Earnings : 12.6 x 44.03 / 3.49 = Takeda Pharm - Tokyo Nikkei 225 Pharmaceuticals MARGIN OF SAFETY : 122.01 % Long Term Growth : 7.98 % Price / Earnings : 11.0 x 3860 / 350.50 = Abbott Labs - U.S.A. SP 500 Pharmaceuticals MARGIN OF SAFETY : 110.19 % Long Term Growth : 8.12 % Price / Earnings : 11.8 x 43.32 / 3.68 = Allergan - U.S.A. SP 500 Pharmaceuticals MARGIN OF SAFETY : 106.31 % Long Term Growth : 12.36 % Price / Earnings : 16.1 x 43.79 / 2.72 = Cipla Ltd - India Nifty50 Pharmaceuticals MARGIN OF SAFETY : 105.63 % Long Term Growth : 12.73 % Price / Earnings : 16.5 x 222.95 / 13.50 = Johnson&Johnson - U.S.A. DOW JONES 30 Pharmaceuticals MARGIN OF SAFETY : 104.19 % Long Term Growth : 8.23 % Price / Earnings : 12.2 x 54.99 / 4.50 = Eisai - Tokyo Nikkei 225 Pharmaceuticals MARGIN OF SAFETY : 98.52 % Long Term Growth : 9.42 % Price / Earnings : 13.8 x 3050 / 221.50 = Dr Reddys Labs - India Nifty50 Pharmaceuticals MARGIN OF SAFETY : 91.36 % Long Term Growth : 10.82 % Price / Earnings : 15.8 x 660.95 / 41.95 = King Pharma - U.S.A. SP 500 Pharmaceuticals MARGIN OF SAFETY : 89.77 % Long Term Growth : 4.21 % Price / Earnings : 8.9 x 8.74 / 0.98 = Shionogi - Tokyo Nikkei 225 Pharmaceuticals MARGIN OF SAFETY : 81.75 % Long Term Growth : 11.71 % Price / Earnings : 17.6 x 1846 / 105.09 = GlaxoSmith P - India Nifty50 Pharmaceuticals MARGIN OF SAFETY : 71.17 % Long Term Growth : 11.32 % Price / Earnings : 18.2 x 1096.25 / 60.25 = Boiron - France Mid&Small 190 Pharmaceuticals MARGIN OF SAFETY : 56.40 % Long Term Growth : 4.22 % Price / Earnings : 10.8 x 19.5 / 1.80 = Bristol Myers - U.S.A. SP 500 Pharmaceuticals MARGIN OF SAFETY : 32.57 % Long Term Growth : 2.79 % Price / Earnings : 10.6 x 20.39 / 1.92 = Stallergenes - France Mid&Small 190 Pharmaceuticals MARGIN OF SAFETY : 2.07 % Long Term Growth : 12.50 % Price / Earnings : 32.8 x 47.58 / 1.45 = Dainpn Sumi Phar - Tokyo Nikkei 225 Pharmaceuticals MARGIN OF SAFETY : 0.00 % Long Term Growth : 0.00 % Price / Earnings : 20.2 x 773 / 38.30 = DAIICHI SANKYO - Tokyo Nikkei 225 Pharmaceuticals MARGIN OF SAFETY : 0.00 % Long Term Growth : 0.00 % Price / Earnings : 28.6 x 1677 / 58.72 = SH Dingli - China Shangaï-B Pharmaceuticals MARGIN OF SAFETY : 0.00 % Long Term Growth : 0.00 % Price / Earnings : 11.0 x 0.44 / 0.04 = Cardiome Pharma - Canada SP/TSX Comp. Pharmaceuticals MARGIN OF SAFETY : 0.00 % Long Term Growth : 0.00 % Price / Earnings : -13.7 x 4.66 / -0.34 = Ipsen - France Mid&Small 190 Pharmaceuticals MARGIN OF SAFETY : 0.00 % Long Term Growth : 0.00 % Price / Earnings : 19.3 x 32.17 / 1.67 = Merck - U.S.A. DOW JONES 30 Pharmaceuticals MARGIN OF SAFETY : 0.00 % Long Term Growth : 0.00 % Price / Earnings : 8.1 x 26.12 / 3.22 = Sepracor - U.S.A. Nasdaq 100 Pharmaceuticals MARGIN OF SAFETY : 0.00 % Long Term Growth : 0.00 % Price / Earnings : 5.7 x 14.23 / 2.48 = Schering Plough - U.S.A. SP 500 Pharmaceuticals MARGIN OF SAFETY : 0.00 % Long Term Growth : 0.00 % Price / Earnings : 13.8 x 23.68 / 1.72 = Shire - U.K. FTSE 100 Pharmaceuticals MARGIN OF SAFETY : 0.00 % Long Term Growth : 0.00 % Price / Earnings : 859.3 x 876.5 / 1.02 = UCB - Belgium BEL20 Pharmaceuticals MARGIN OF SAFETY : 0.00 % Long Term Growth : 0.00 % Price / Earnings : 18.5 x 22.93 / 1.24 = Watson Pharma - U.S.A. SP 500 Pharmaceuticals MARGIN OF SAFETY : 0.00 % Long Term Growth : 0.00 % Price / Earnings : 12.3 x 29.85 / 2.42 = CHUGAI PHARM - Tokyo Nikkei 225 Pharmaceuticals MARGIN OF SAFETY : -17.60 % Long Term Growth : 5.62 % Price / Earnings : 24.0 x 1787 / 74.60 = Kyowa Hakko K - Tokyo Nikkei 225 Pharmaceuticals MARGIN OF SAFETY : -44.33 % Long Term Growth : 6.47 % Price / Earnings : 38.5 x 966 / 25.09 = Ranbaxy Labs - India Nifty50 Pharmaceuticals MARGIN OF SAFETY : -85.47 % Long Term Growth : 0.32 % Price / Earnings : 62.9 x 220.25 / 3.50 = AstraZeneca - U.K. FTSE 100 Pharmaceuticals MARGIN OF SAFETY : -94.72 % Long Term Growth : 9.83 % Price / Earnings : 533.5 x 2646 / 4.96 =